115 related articles for article (PubMed ID: 14640830)
21. Cognitive performance enhancement: misuse or self-treatment?
Peterkin AL; Crone CC; Sheridan MJ; Wise TN
J Atten Disord; 2011 May; 15(4):263-8. PubMed ID: 20410324
[TBL] [Abstract][Full Text] [Related]
22. Acute nicotine improves cognitive deficits in young adults with attention-deficit/hyperactivity disorder.
Potter AS; Newhouse PA
Pharmacol Biochem Behav; 2008 Feb; 88(4):407-17. PubMed ID: 18022679
[TBL] [Abstract][Full Text] [Related]
23. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P
Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
[TBL] [Abstract][Full Text] [Related]
24. Parental angst making and revisiting decisions about treatment of attention-deficit/hyperactivity disorder.
Brinkman WB; Sherman SN; Zmitrovich AR; Visscher MO; Crosby LE; Phelan KJ; Donovan EF
Pediatrics; 2009 Aug; 124(2):580-9. PubMed ID: 19651580
[TBL] [Abstract][Full Text] [Related]
25. The nature of the relationship between attention-deficit/hyperactivity disorder and substance use.
Wilens TE
J Clin Psychiatry; 2007; 68 Suppl 11():4-8. PubMed ID: 18307375
[TBL] [Abstract][Full Text] [Related]
26. College students with and without ADHD: comparison of self-report of medication usage, study habits, and academic achievement.
Advokat C; Lane SM; Luo C
J Atten Disord; 2011 Nov; 15(8):656-66. PubMed ID: 20679154
[TBL] [Abstract][Full Text] [Related]
27. National estimates and factors associated with medication treatment for childhood attention-deficit/hyperactivity disorder.
Visser SN; Lesesne CA; Perou R
Pediatrics; 2007 Feb; 119 Suppl 1():S99-106. PubMed ID: 17272592
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of theophylline compared to methylphenidate for the treatment of attention-deficit hyperactivity disorder in children and adolescents: a pilot double-blind randomized trial.
Mohammadi MR; Kashani L; Akhondzadeh S; Izadian ES; Ohadinia S
J Clin Pharm Ther; 2004 Apr; 29(2):139-44. PubMed ID: 15068402
[TBL] [Abstract][Full Text] [Related]
29. Attention deficit hyperactivity disorder symptoms mediate early-onset smoking.
Huizink AC; van Lier PA; Crijnen AA
Eur Addict Res; 2009; 15(1):1-9. PubMed ID: 19052457
[TBL] [Abstract][Full Text] [Related]
30. Impact of ADHD and its treatment on substance abuse in adults.
Wilens TE
J Clin Psychiatry; 2004; 65 Suppl 3():38-45. PubMed ID: 15046534
[TBL] [Abstract][Full Text] [Related]
31. Sleep in children with attention-deficit hyperactivity disorder (ADHD): a review of naturalistic and stimulant intervention studies.
Cohen-Zion M; Ancoli-Israel S
Sleep Med Rev; 2004 Oct; 8(5):379-402. PubMed ID: 15336238
[TBL] [Abstract][Full Text] [Related]
32. Emergency department use and costs for youth with attention-deficit/hyperactivity disorder: associations with stimulant treatment.
Leibson CL; Barbaresi WJ; Ransom J; Colligan RC; Kemner J; Weaver AL; Katusic SK
Ambul Pediatr; 2006; 6(1):45-53. PubMed ID: 16443183
[TBL] [Abstract][Full Text] [Related]
33. A post hoc subgroup analysis of an 18-day randomized controlled trial comparing the tolerability and efficacy of mixed amphetamine salts extended release and atomoxetine in school-age girls with attention-deficit/hyperactivity disorder.
Biederman J; Wigal SB; Spencer TJ; McGough JJ; Mays DA
Clin Ther; 2006 Feb; 28(2):280-93. PubMed ID: 16678649
[TBL] [Abstract][Full Text] [Related]
34. The diagnosis and medical treatment of ADHD in children and adolescents in primary care: a practical guide.
Woodard R
Pediatr Nurs; 2006; 32(4):363-70. PubMed ID: 16927730
[TBL] [Abstract][Full Text] [Related]
35. Pharmacotherapy of adult ADHD.
Dodson WW
J Clin Psychol; 2005 May; 61(5):589-606. PubMed ID: 15723384
[TBL] [Abstract][Full Text] [Related]
36. Methylphenidate in the treatment of female adolescents with cooccurrence of attention deficit/hyperactivity disorder and borderline personality disorder: a preliminary open-label trial.
Golubchik P; Sever J; Zalsman G; Weizman A
Int Clin Psychopharmacol; 2008 Jul; 23(4):228-31. PubMed ID: 18446088
[TBL] [Abstract][Full Text] [Related]
37. Integrated pharmacologic treatment of attention-deficit hyperactivity disorder (ADHD).
Horst RO; Hendren RL
Essent Psychopharmacol; 2005; 6(5):250-61. PubMed ID: 16222910
[TBL] [Abstract][Full Text] [Related]
38. An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder.
Chavez B; Sopko MA; Ehret MJ; Paulino RE; Goldberg KR; Angstadt K; Bogart GT
Ann Pharmacother; 2009 Jun; 43(6):1084-95. PubMed ID: 19470858
[TBL] [Abstract][Full Text] [Related]
39. Stimulants: use and abuse in the treatment of attention deficit hyperactivity disorder.
Fone KC; Nutt DJ
Curr Opin Pharmacol; 2005 Feb; 5(1):87-93. PubMed ID: 15661631
[TBL] [Abstract][Full Text] [Related]
40. The misuse and diversion of prescribed ADHD medications by college students.
Rabiner DL; Anastopoulos AD; Costello EJ; Hoyle RH; McCabe SE; Swartzwelder HS
J Atten Disord; 2009 Sep; 13(2):144-53. PubMed ID: 19448150
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
